Bridgefront Capital’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,263
Closed -$257K 642
2025
Q1
$257K Buy
+4,263
New +$275K 0.07% 438
2024
Q4
Sell
-3,598
Closed -$259K 617
2024
Q3
$259K Sell
3,598
-2,101
-37% -$148K 0.1% 378
2024
Q2
$395K Buy
5,699
+2,798
+96% +$204K 0.16% 219
2024
Q1
$232K Buy
+2,901
New +$259K 0.18% 277

Other funds holding CNMD

Bridgefront Capital's CNMD Position: Q2 2025 in Review

Bridgefront Capital sold out of CONMED (CNMD) in Q2 2025, closing a stake of 4,263 shares — an estimated $257K sold.

Bridgefront Capital first reported a position in CNMD in Q1 2024 and held it in 4 quarters. The position peaked at $395K in Q2 2024. 276 funds tracked by Wall St. Rank hold CNMD as of Q2 2025.

  • Bridgefront Capital reported no remaining CONMED position as of Q2 2025 after selling out during the quarter.
  • Bridgefront Capital sold 4,263 CONMED shares in Q2 2025, an estimated $257K.
  • Bridgefront Capital first reported a position in CONMED in Q1 2024 and held it in 4 quarters.
  • Bridgefront Capital's CONMED position peaked at $395K in Q2 2024.
  • 276 funds tracked by Wall St. Rank held CONMED as of Q2 2025.

Based on Bridgefront Capital's 13F filing for Q2 2025, filed 14 Aug 2025.